GTR 92918226
Tenders Are Invited For Pharmaceutical Products – Lijekovi 2
ICB — International Competitive Bid
Closed
Southern Europe
Tender Information
GTR Reference
92918226
Tendering Authority
Subscribe to view
Tender No
114482-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Lijekovi 2
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Southern Europe
Last Date of Bid Submission
24-03-2025
Closed
Work Detail
Pharmaceutical Products – Lijekovi 2. 1.Ocrelizumab - 300 Mg/10 Ml,2.Ocrelizumab - 920 Mg/23 Ml (40 Mg/Ml),3.Teriflunomide - 14 Mg,4.Fremanezumab - 225 Mg/1,5 Ml,5.Fingolimod – 0,5 Mg,6.Cladribine - 10 Mg,7.Natalizumab - 150 Mg/Ml,8.Ofatumumab - 20 Mg/0,4 Ml
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
640080d3-1560-4b21-95f7-b2cf06818215.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.